Octagon Capital Advisors as of June 30, 2021
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 34 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 16.4 | $79M | 1.3M | 63.20 | |
| I Mab Sponsored Ads (IMAB) | 16.4 | $79M | 943k | 83.95 | |
| Curis Com New | 6.0 | $29M | 3.6M | 8.07 | |
| Bridgebio Pharma (BBIO) | 4.8 | $23M | 381k | 60.96 | |
| Arcus Biosciences Incorporated (RCUS) | 4.3 | $21M | 760k | 27.46 | |
| 4d Molecular Therapeutics In (FDMT) | 4.1 | $20M | 831k | 24.08 | |
| Zai Lab Adr (ZLAB) | 4.0 | $19M | 109k | 176.99 | |
| Celldex Therapeutics Com New (CLDX) | 3.9 | $19M | 561k | 33.44 | |
| Vera Therapeutics Cl A (VERA) | 3.1 | $15M | 1.1M | 13.25 | |
| Acceleron Pharma | 2.9 | $14M | 112k | 125.49 | |
| Arvinas Ord (ARVN) | 2.8 | $14M | 179k | 77.00 | |
| Dyne Therapeutics (DYN) | 2.5 | $12M | 584k | 21.04 | |
| Century Therapeutics (IPSC) | 2.5 | $12M | 404k | 29.34 | |
| Gossamer Bio (GOSS) | 2.4 | $12M | 1.4M | 8.12 | |
| Avidity Biosciences Ord (RNA) | 2.3 | $11M | 447k | 24.71 | |
| Stoke Therapeutics (STOK) | 2.1 | $10M | 297k | 33.66 | |
| Ambrx Biopharma Sponsored Ads | 1.8 | $8.8M | 450k | 19.60 | |
| Pmv Pharmaceuticals (PMVP) | 1.8 | $8.5M | 250k | 34.16 | |
| Connect Biopharma Hldgs Ads (CNTB) | 1.5 | $7.3M | 374k | 19.53 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.4 | $6.8M | 320k | 21.20 | |
| Cardiff Oncology (CRDF) | 1.4 | $6.5M | 983k | 6.65 | |
| Ikena Oncology (IKNA) | 1.2 | $5.6M | 400k | 14.04 | |
| Monte Rosa Therapeutics (GLUE) | 1.1 | $5.4M | 238k | 22.70 | |
| Design Therapeutics (DSGN) | 1.0 | $5.0M | 250k | 19.89 | |
| Prometheus Biosciences | 1.0 | $4.9M | 200k | 24.56 | |
| Kymera Therapeutics (KYMR) | 1.0 | $4.9M | 100k | 48.50 | |
| Merus N V (MRUS) | 0.9 | $4.4M | 207k | 21.07 | |
| Iveric Bio | 0.9 | $4.3M | 680k | 6.31 | |
| Helix Acquisition Corp Com Cl A | 0.9 | $4.1M | 400k | 10.33 | |
| Revolution Medicines (RVMD) | 0.8 | $4.0M | 126k | 31.74 | |
| Ngm Biopharmaceuticals (NGM) | 0.8 | $3.9M | 200k | 19.72 | |
| Kronos Bio (KRON) | 0.7 | $3.5M | 146k | 23.95 | |
| Jiya Acquisition Corp Com Cl A | 0.6 | $3.0M | 300k | 9.94 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $2.7M | 125k | 21.33 |
